Eli Kalif-Executive Vice President, Chief Financial Officer (CFO)

Eli Kalif

Executive Vice President, Chief Financial Officer (CFO)

Eli Kalif leads the Global Finance and IT organizations, based in Teva’s headquarters in Israel.

Eli Kalif was appointed Executive Vice President, Chief Financial Officer in December 2019, with primary responsibility for leading Teva's financial strategy and overseeing all the finance activities of the company, including treasury, financial planning and analysis, accounting, taxation matters and investor relations. Eli is also responsible for Teva's Information Technology (IT) globally and for setting up the Global Business Services function.

Teva’s Global Finance Group is a business partner to Teva's Global, Regional and BU leadership teams, ensuring that Teva has the right financial resources and tools to deliver on its objectives. Teva shares are listed on both the New York Stock Exchange and Tel Aviv Stock Exchange.

Eli is a senior finance executive with more than twenty years’ experience in corporate and operational finance, bringing proven leadership capabilities as well as deep functional expertise and technical knowledge in all aspects of corporate finance, financial planning and accounting. He possesses a profound understanding of global production structures and has experience in leading organizational transformations, as well as building world class financial organizations. Prior to joining Teva, Eli held various leadership and senior executive finance positions in Flex Ltd., a global technology design and manufacturing service provider. He was responsible for leading global finance teams.

Eli is a graduate of Stanford University and MIT Sloan executive programs and holds a BA degree in Accounting and Economics from the College of Management Academic Studies in Israel. He is also a certified Public Accountant (CPA). 


Richard Francis joined as Chief Executive Officer (CEO) of Teva Pharmaceutical Industries in January 2023

Richard Francis

President and Chief Executive Officer, Member of the Board of Directors

Read more
Richard Daniell, Executive Vice President, European Commercial

Richard Daniell

Executive Vice President, European Commercial

Read more
Christine Fox, Executive Vice President, U.S. Commercial

Christine Fox

Executive Vice President, U.S. Commercial

Read more
Angus J. Grant, PhD, Executive Vice President, Business Development

Angus J. Grant, PhD

Executive Vice President, Business Development

Read more
Dr. Eric A. Hughes, Executive Vice President, Global R&D and Chief Medical Officer

Dr. Eric A. Hughes

Executive Vice President, Global R&D and Chief Medical Officer

Read more

Placid Jover

Executive Vice President, Chief Human Resources Officer

Read more
David McAvoy - Teva Pharmaceuticals Chief Legal Officer

David McAvoy

Executive Vice President, Chief Legal Officer

Read more
Mark Sabag, Executive Vice President, International Markets Commercial

Mark Sabag

Executive Vice President, International Markets Commercial

Read more
Matthew Shields, Executive Vice President, Teva Global Operations

Matthew Shields

Executive Vice President, Teva Global Operations

Read more
Nir Baron, Senior Vice President, Chief Internal Auditor

Nir Baron

Senior Vice President, Chief Internal Auditor

Read more
Kathleen Veit, Senior Vice President, Global Compliance & Ethics Officer

Kathleen Veit

Senior Vice President, Global Compliance & Ethics Officer

Read more